Industry Satellite Symposia webcasts

01/12/2023

Astellas
Transformation of gastric cancer management in the past decade (from BSC to chemo to targeted + IO)  

Watch session

• Transformation of gastric cancer management in the past decade (from BSC to chemo to targeted + IO)    
  Raghav Sundar
• Novel targeted therapy approaches in gastric cancer    
  Elizabeth Smyth
• Claudin as a therapeutic target in gastric cancer    
• Kohei Shitara
• Biomarker testing in gastric cancer: Solving practical issues and surmounting challenges    
  matteo fassan
• Panel discussion on the challenges of the management of gastric cancer    
• Conclusion    
  Raghav Sundar

GSK
Evolving role of immune checkpoint inhibitors (ICIs) in solid tumors: Expert perspectives 

Watch session   

• Breakthrough evolution in treatment landscape for solid tumors with ICIs    
  Wen Son Hsieh
• Key considerations in advanced/recurrent treatment of EC    
  David SP Tan
• Perspective on single-agent PD-1 blockade in dMMR CRC/solid tumors    
  Takayuki Yoshino
• Novel checkpoint combinations for advanced NSCLC    
  Byoung Chul Cho
• General Q&A and closing

Ipsen Pharma
Exploring optimal management of advanced RCC, HCC and RAI-DTC   

Watch session

• Welcome and opening    
  Seng-Weng Wong
• Advances in management of advanced RCC    
  Chang Gon Kim
• Optimal sequencing in the hepatocellular carcinoma    
  Stephen Chan
• Treatment sequencing in RAI-DTC    
  Jaume Capdevila Castillon
• Q&A    
• Closing    
  Seng-Weng Wong

Seagen
What’s next for ADCs in oncology?

Watch session

• Welcome and introduction    
  Solange Peters
• State of the art and perspectives    
  Solange Peters
• Advances in integrin targeting    
  Kenneth O'Byrne
• Multimodal immune targeting with ADCs    
  Emiliano Calvo
• Panel discussion, live Q&A, and conclusions 

03/12/2023

BMS
Expanding the role of immuno-oncology in GI cancers: Best practices and clinical questions   

Watch session

• Welcome and introduction    
  Wei Peng Yong
• Update on immuno-oncology for the treatment of gastric and esophageal cancers    
  Ken Kato
• Update on immuno-oncology for the treatment of colorectal cancer  
  Niall Tebbutt
• Roundtable case discussion, Q&A, and summary    
• Close    
  Wei Peng Yong